The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Topic summary

Holding a dose indefinitely: is there a documented downside?

This is a generated summary. It shows the 5 most-liked posts from a topic of 33, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.
MP
mira.patelTL4 Admin28 Jan 2025 · edited#8
peak_purity, post #4: The maximum studied dose is a fact about the trial and not a ceiling on the molecule. It is also the last point at which anything is known, which is the reason to treat it as one. The confident version of this sentence would be wrong, so here is the hedged one. Go to post

Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.

Marking that as an opinion rather than a finding.

24 likes in reply to #4 18mo
SL
s.leclercTL4 Moderator4 Mar 2025#12
h.falk, post #1: Holding a dose indefinitely: is there a documented downside? — that is the question, and I have not found it answered plainly anywhere I have looked. I have read the maintained page on this and I still have a gap, so I am asking rather than guessing. Context: tirzepatide, 5 weeks in, currently at a dose I reached by the standard… Go to post

When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea, constipation, injection discomfort), reducing the dose is a reasonable response. If the side effect is not dose-dependent (e.g., hypoglycemia with insulin), dose reduction does not address the issue.

I have deliberately not rounded that, because the rounding is where the argument starts.

32 likes in reply to #1 17mo
MC
m.coelhoTL227 Apr 2025#19

I read post #17 twice before replying, because I had assumed the opposite.

Writing down the date, the dose and the site each week takes fifteen seconds and is the single most useful record anyone here keeps. Memory reconstructs a titration history that never happened.

33 likes 15mo
KA
k.agyemanTL227 May 2025#23

Marking my place. If it changes for me I will come back and say so.

32 likes 14mo
NS
no.silvaTL227 Jul 2025#32

If someone has run holding a dose properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.

27 likes 12mo

Read the full topic (33 posts)

Suggested topics

TopicParticipantsRepliesViewsActivity
Revisiting: The arithmetic of an intermediate dose between two label steps
Revisiting: The arithmetic of an intermediate dose between two label steps Writing it up because I had to work it out twice and would rather nobody else did. I have read the maintained page on this and I…
CSRHGBWTMR+41 45 808 2mo
[2026 update] Dose numbers across compounds are not on the same scale
On the subject in the title: Dose numbers across compounds are not on the same scale Working notes rather than a conclusion. A narrow question about Dose numbers across compounds, deliberately narrow, because…
KVBVHDITNL+14 18 1.2k 13mo
Where the four-week escalation interval comes from, and what it is not
On the subject in the title: Where the four-week escalation interval comes from, and what it is not Working notes rather than a conclusion. Working notes on four-week escalation interval rather than a…
CCNWVNRW+56 60 21k 2y
Coming back to: Where the four-week escalation interval comes from, and what it is not
Posting this under the heading it deserves: Where the four-week escalation interval comes from, and what it is not Everything below is what sits behind that. Four-week escalation interval — I have the…
AKPIHISSFF+44 48 11k 1d
Why "dose equivalence" between different incretin analogues is a weak concept
Why "dose equivalence" between different incretin analogues is a weak concept I have a specific reason for asking rather than idle curiosity, and the context is below. I have read the maintained page on this…
WVERFYWMB+124 133 11k 5mo

Related topics — sharing the tags dose reduction, missed dose, semaglutide

TopicParticipantsRepliesViewsActivity
[2026 update] Dose numbers across compounds are not on the same scale
On the subject in the title: Dose numbers across compounds are not on the same scale Working notes rather than a conclusion. A narrow question about Dose numbers across compounds, deliberately narrow, because…
KVBVHDITNL+14 18 1.2k 13mo
Reaching a dose and staying there for a year: a longitudinal note
Reaching a dose and staying there for a year: a longitudinal note Writing it up because I had to work it out twice and would rather nobody else did. I have read the maintained page on this and I still have a…
RFNRHC 2 763 15mo
Amylin receptor signalling and satiety
Amylin receptor signalling and satiety Writing it up because I had to work it out twice and would rather nobody else did. Asking about amylin receptor signalling and satiety directly, because I have read four…
SGBCTNNATT+22 26 1.8k 9mo
How the published trials escalated, tabulated side by side — does this still hold?
Asking directly, because I could not find a straight answer: How the published trials escalated, tabulated side by side — does this still hold? Asking about published trials escalated directly, because I have…
MAEKSS 2 8.9k 9mo
Drawing from a pen cartridge with a syringe: how the risk profile changes
Posting this under the heading it deserves: Drawing from a pen cartridge with a syringe: how the risk profile changes Everything below is what sits behind that. Question about a metering device rather than…
IDWSR 2 159 19mo